NCT03190655

Brief Summary

Burn injury is the result of an energy transfer that destroys the skin and adjacent tissues. Partial thickness burn wounds are painful and difficult to manage. The aim of burn treatment in partial thickness burns is to promote rapid wound healing, decrease pain, protect wound from infections, minimize scar formation and functional impairment In recent years, there are progressive development of new dressing material with a variety of option for depth adapted wound management. Many wound dressings are available for superficial and partial thickness burns. Hydrogel based wound dressing provides good biocompatibility with the skin and mucosa and promotes hydration of the wound bed. Aluminaid wound dressings is a hydrogel based wound dressing that is integrated with aluminium that was designed to reduce acute pain in the treatment of superficial and partical thickness burn injuries. Up to date, no evidence regarding integrated with aluminium sheet in hydrogel based wound dressings for the use in partial thickness burns. Therefore this trials is aimed to evaluate the efficacy and safety of Aluminaid versus Hydrogel for the treatment of partial thickness burns.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2017

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2017

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

June 12, 2017

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 19, 2017

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 5, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 5, 2018

Completed
Last Updated

March 12, 2018

Status Verified

March 1, 2018

Enrollment Period

1 year

First QC Date

June 12, 2017

Last Update Submit

March 9, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Wound healing

    Wound healing as determine by the time of complete re-epithelization of the study area, in days.

    Up to 21 days

Secondary Outcomes (4)

  • Erythema

    at the time of admission up to 30 minutes

  • Bullae

    at the time of admission up to 30 minutes

  • Pain score

    At the time of admission up to 30 minutes and 1st week of follow up

  • Adverse events

    At the time of admission up to 21 days of follow up

Study Arms (2)

Aluminaid

EXPERIMENTAL

Treatment group: Aluminaid wound dressing

Device: Aluminaid

Hydrogel

ACTIVE COMPARATOR

Hydrogel wound dressing (Trademark: Burnshield)

Device: Hydrogel

Interventions

AluminaidDEVICE

Aluminaid wound dressings is a hydrogel based wound dressing that is integrated with aluminium

Aluminaid
HydrogelDEVICE

Hydrogel based wound dressing

Hydrogel

Eligibility Criteria

Age12 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Adults and children of 12 - 65 years old
  • Partial thickness thermal burns of minimally 1% total body surface area (TBSA)
  • Admission of less than 4 hours of burn injury
  • Patients/legal guardian still have the ability to undergo examinations and give written informed consent.

You may not qualify if:

  • Total body surface area (TBSA) of more than 20%
  • Burns caused by chemicals, electricity or radiation
  • Superficial and partial thickness burns located on the faces, palms, soles, genitalia, perineum and joint areas
  • Superficial and partial thickness burns with compartment syndrome
  • Superficial and partial thickness burns with a history of life-threatening trauma
  • Had concomitant disease such as diabetes mellitus
  • Signs of infected burns
  • Patients with known allergies to product containing aluminium, hydrogel or a history of contact dermatitis
  • Other conditions which according to the investigator's judgment are not appropriate to be included in the study.
  • Treated with other agents before attend to clinic (oil, tooth paste, betadine, rivanol etc)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinic of Clinical Research Supporting Unit

Jakarta Pusat, Jakarta Special Capital Region, 10430, Indonesia

Location

Related Publications (8)

  • Grippaudo FR, Carini L, Baldini R. Procutase versus 1% silver sulphadiazine in the treatment of minor burns. Burns. 2010 Sep;36(6):871-5. doi: 10.1016/j.burns.2009.10.021. Epub 2010 Jan 15.

    PMID: 20079572BACKGROUND
  • Cancio LC, Lundy JB, Sheridan RL. Evolving changes in the management of burns and environmental injuries. Surg Clin North Am. 2012 Aug;92(4):959-86, ix. doi: 10.1016/j.suc.2012.06.002.

    PMID: 22850157BACKGROUND
  • Hettiaratchy S, Dziewulski P. ABC of burns: pathophysiology and types of burns. BMJ. 2004 Jun 12;328(7453):1427-9. doi: 10.1136/bmj.328.7453.1427. No abstract available.

    PMID: 15191982BACKGROUND
  • Lars PK, Giretzlehner M, Trop M, Parvizi D, Spendel S, Schintler M, Justich I, Wiedner M, Laback C, Lumenta DB. The properties of the "ideal" donor site dressing: results of a worldwide online survey. Ann Burns Fire Disasters. 2013 Sep 30;26(3):136-41.

    PMID: 24563639BACKGROUND
  • Rowan MP, Cancio LC, Elster EA, Burmeister DM, Rose LF, Natesan S, Chan RK, Christy RJ, Chung KK. Burn wound healing and treatment: review and advancements. Crit Care. 2015 Jun 12;19:243. doi: 10.1186/s13054-015-0961-2.

    PMID: 26067660BACKGROUND
  • Selig HF, Lumenta DB, Giretzlehner M, Jeschke MG, Upton D, Kamolz LP. The properties of an "ideal" burn wound dressing--what do we need in daily clinical practice? Results of a worldwide online survey among burn care specialists. Burns. 2012 Nov;38(7):960-6. doi: 10.1016/j.burns.2012.04.007. Epub 2012 May 8.

    PMID: 22571855BACKGROUND
  • Serrano C, Boloix-Tortosa R, Gomez-Cia T, Acha B. Features identification for automatic burn classification. Burns. 2015 Dec;41(8):1883-1890. doi: 10.1016/j.burns.2015.05.011. Epub 2015 Jul 15.

    PMID: 26188898BACKGROUND
  • Wasiak J, Cleland H, Campbell F, Spinks A. Dressings for superficial and partial thickness burns. Cochrane Database Syst Rev. 2013 Mar 28;2013(3):CD002106. doi: 10.1002/14651858.CD002106.pub4.

    PMID: 23543513BACKGROUND

MeSH Terms

Interventions

Bandages, Hydrocolloid

Intervention Hierarchy (Ancestors)

BandagesEquipment and Supplies

Study Officials

  • Wawaimuli Arozal, MD, PhD

    Indonesia University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
The person that assess the degree of epithelization will be presented with photos of the burn conditions and will not be given information of the patient's treatment.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Patients who attend the clinical sites, presenting with untreated partial thickness burns less than 4 hours, and meet the inclusion and exclusion criteria
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Trial Director

Study Record Dates

First Submitted

June 12, 2017

First Posted

June 19, 2017

Study Start

March 1, 2017

Primary Completion

March 5, 2018

Study Completion

March 5, 2018

Last Updated

March 12, 2018

Record last verified: 2018-03

Data Sharing

IPD Sharing
Will not share

Locations